Comparison of botulinum toxin type A administered at different dilutions in patients with clonic hemifacial spasm
Journal of Parkinson's Disease and Movement Disorders · 29.07.2026 · 29 (2) · 59-66
DOI: 10.5606/phhb.dergisi.2026.77 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parkinson's Disease and Movement Disorders, online erschienen am 29.07.2026. Verfasst von Hanife Şentürk und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
This study aims to compare the motor, functional, and psychosocial clinical changes and post-procedural injection pain following administration of the same total dose of botulinum toxin type A (BoNT-A) diluted with 2 mL versus 1 mL of physiological saline (PS) in patients with hemifacial spasm (HFS). Materials and Methods: This prospective study included patients with HFS, older than 18 years, who had either not previously received BoNT-A or in whom at least six months had elapsed since the last administration. Data from 21 patients who completed both application periods were analyzed. In the first application, BoNT-A was administered diluted with 2 mL of PS (0.9% NaCl), and in the subsequent period, the same total dose was diluted with 1 mL of PS. Patients were evaluated one month after each application using the Hemifacial Spasm Score; procedural pain was assessed with a 0-10 Visual Analog Scale (VAS). Changes from baseline were calculated and the dilution methods compared using the Wilcoxon signed-rank test (p < 0.05).
Results
The mean age was 51.62 ± 13.00 years. One month after both applications, a significant decrease from baseline was observed in the severity and frequency of contractions, disease-related complaints, functional difficulties, and all psychosocial parameters. When the changes produced by the two methods were compared, no significant difference was found in the main motor parameters; however, improvement in difficulty reading, depressive mood, avoidance of eye contact, and feeling of embarrassment was greater with the 1 mL application (p = 0.010, p = 0.002, p = 0.007, and p = 0.003, respectively). The post-procedural VAS score was 2.43 ± 2.20 with 2 mL and 0.29 ± 0.78 with 1 mL, with significantly lower injection pain in the 1 mL application (p < 0.001). No adverse effects were observed.
Conclusion
Administration of the same total BoNT-A dose diluted with either 1 mL or 2 mL of PS provided marked improvement in the motor symptoms of HFS, with no significant difference between the two dilutions in the main motor efficacy parameters. The 1 mL application was associated with lower injection pain and greater improvement in some functional-psychosocial parameters.
Zitieren
APA
Şentürk, H., Altun, İ. G., & Barut, B. Ö. (2026). Comparison of botulinum toxin type A administered at different dilutions in patients with clonic hemifacial spasm. Journal of Parkinson's Disease and Movement Disorders, 29(2), 59-66. https://doi.org/10.5606/phhb.dergisi.2026.77
Vancouver
Şentürk H, Altun İG, Barut BÖ. Comparison of botulinum toxin type A administered at different dilutions in patients with clonic hemifacial spasm. Journal of Parkinson's Disease and Movement Disorders. 2026;29(2):59-66. doi:10.5606/phhb.dergisi.2026.77
BibTeX
@article{entrk2026,
author = {Şentürk, Hanife and Altun, İlknur Güçlü and Barut, Banu Özen},
title = {Comparison of botulinum toxin type A administered at different dilutions in patients with clonic hemifacial spasm},
journal = {Journal of Parkinson's Disease and Movement Disorders},
year = {2026},
volume = {29},
number = {2},
pages = {59--66},
doi = {10.5606/phhb.dergisi.2026.77}
}
EUVIMED